Mirum Pharmaceuticals Inc’s filing revealed that its SVP, GLOBAL CONTROLLER Howe Jolanda unloaded Company’s shares for reported $0.11 million on Mar 18 ’25. In the deal valued at $44.45 per share,2,415 shares were sold. As a result of this transaction, Howe Jolanda now holds 2,426 shares worth roughly $95390.32.
Then, Howe Jolanda sold 57,606 shares, generating $2,554,763 in total proceeds. Upon selling the shares at $44.35, the SVP, GLOBAL CONTROLLER now owns 4,841 shares.
Before that, Radovich Peter sold 7,879 shares. Mirum Pharmaceuticals Inc shares valued at $348,364 were divested by the PRESIDENT AND COO at a price of $44.21 per share. As a result of the transaction, Radovich Peter now holds 18,672 shares, worth roughly $0.73 million.
Stifel initiated its Mirum Pharmaceuticals Inc [MIRM] rating to a Buy in a research note published on April 17, 2024; the price target was $48. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who remained covering the stock and in mid December has reiterated a ‘”a Buy”‘ rating for it. Morgan Stanley started covering the stock on November 13, 2023. It rated MIRM as “an Overweight”.
Price Performance Review of MIRM
On Tuesday, Mirum Pharmaceuticals Inc [NASDAQ:MIRM] saw its stock fall -4.10% to $39.32. Over the last five days, the stock has lost -10.72%. Mirum Pharmaceuticals Inc shares have fallen nearly -4.91% since the year began. Nevertheless, the stocks have risen 49.73% over the past one year. While a 52-week high of $54.23 was reached on 02/21/25, a 52-week low of $23.14 was recorded on 04/08/25. SMA at 50 days reached $47.27, while 200 days put it at $42.51.
Levels Of Support And Resistance For MIRM Stock
The 24-hour chart illustrates a support level at 37.34, which if violated will result in even more drops to 35.36. On the upside, there is a resistance level at 42.23. A further resistance level may holdings at 45.14. The Relative Strength Index (RSI) on the 14-day chart is 27.27, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.00, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.21%. Stochastics %K at 12.10% indicates the stock is a buying.
How much short interest is there in Mirum Pharmaceuticals Inc?
A steep rise in short interest was recorded in Mirum Pharmaceuticals Inc stocks on 2025-03-14, dropping by -0.33 million shares to a total of 6.28 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 6.61 million shares. There was a decline of -5.19%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 24, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $50 price target.
